X0508 4 2025-03-05 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001673277 Francis Richard D C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL false true false false President and CEO false Restricted Share Units 2025-03-05 4 A false 169811 0 A Ordinary Shares 169811 169811 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 5, 2025, with 42,452 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Richard D. Francis 2025-03-07